PA
ABVX

Perceptive Advisors’s Abivax ABVX Stock Holding History

Perceptive Advisors’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.86M Sell
74,000
-254,884
-77% -$28.8M 0.15% 81
2026
Q1 		$36.6M Sell
328,884
-129,459
-28% -$15.3M 0.72% 34
2025
Q4 		$61.8M Buy
458,343
+69,735
+18% +$7.61M 1.1% 30
2025
Q3 		$33M Buy
+388,608
New +$23.8M 0.95% 32

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $3.35B AUM 55.08% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Perceptive Advisors's ABVX Position: Q2 2026 in Review

Perceptive Advisors reduced its Abivax (ABVX) stake by 77% in Q2 2026, selling an estimated $28.8M and leaving 74,000 shares worth $9.86M. The position accounts for 0.15% of the portfolio, ranked #81.

Perceptive Advisors first reported a position in ABVX in Q3 2025 and has held it in 4 quarters since. The position peaked at $61.8M in Q4 2025. 302 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • Perceptive Advisors held 74,000 shares of Abivax worth $9.86M as of Q2 2026.
  • Perceptive Advisors sold 254,884 Abivax shares in Q2 2026, an estimated $28.8M.
  • Abivax made up 0.15% of Perceptive Advisors's portfolio in Q2 2026, its #81 holding.
  • Perceptive Advisors first reported a position in Abivax in Q3 2025 and has held it in 4 quarters since.
  • Perceptive Advisors's Abivax position peaked at $61.8M in Q4 2025.
  • 302 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on Perceptive Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.